The overall purpose of the Cell and Tissue Biology Core is to offer specialized services and reagents to Center members that are not readily available in their individual laboratories. Techniques such as primary liver cell culture and liver perfusion are complex and expensive; they cannot be performed without a very substantial investment in equipment and personnel training. Moreover, 20 years of experience have shown clearly that success is operator-dependent. Laboratories that perform these procedures on an occasional basis only are unlikely to achieve reproducible results. For example, when cell isolates are being prepared on a daily basis, as in the Core, small changes in quality are; readily detected and appropriate analysis is done. This is particularly important when new batches of reagents are introduced that may differ in key properties from those in current use. In this case, careful parallel testing is done to ensure that quality is maintained. Also, reagents such as enzymes for tissue dissociation have a limited shelf life. This is not an issue for a busy Core operation but can be important for the individual laboratory that performs the procedure on an occasional basis only. Thus, centralization of these services within a Core permits: (a) technology transfer to a broad range of Center investigators; (b) standardization of techniques with rigorous quality control; and (c) economy of scale. All of these enhance the productivity and efficiency of the Center as a whole. Another important mission of the Cell and Tissue Biology Core is to improve on existing techniques and develop new services as required by Center members. The history in this regard is noteworthy, as described above, and this remains a fundamental part of the Core?s mission and its service to Center investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK026743-21A1
Application #
6675388
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-09-30
Project End
2007-05-31
Budget Start
Budget End
Support Year
21
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Lee, Briton; Holt, Edward W; Wong, Robert J et al. (2018) Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 51:258-264
Roberts, Daniel E; Kakar, Sanjay; Mehta, Neil et al. (2018) A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence. Am J Surg Pathol 42:855-865
Sarkar, Monika; Bramham, Kate; Moritz, Michael J et al. (2018) Reproductive health in women following abdominal organ transplant. Am J Transplant 18:1068-1076
Perito, Emily R; Phelps, Andrew; Vase, Tabitha et al. (2018) Subclinical Atherosclerosis in Pediatric Liver Transplant Recipients: Carotid and Aorta Intima-Media Thickness and Their Predictors. J Pediatr 193:119-127.e1
Schaub, Johanna R; Huppert, Kari A; Kurial, Simone N T et al. (2018) De novo formation of the biliary system by TGF?-mediated hepatocyte transdifferentiation. Nature 557:247-251
Wang, Jingxiao; Dong, Mingjie; Xu, Zhong et al. (2018) Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Oncogene 37:3229-3242
Kotwani, Prashant; Saxena, Varun; Dodge, Jennifer L et al. (2018) History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist. Transplantation 102:794-802
Benet, L Z; Liu, S; Wolfe, A R (2018) The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio. Clin Pharmacol Ther 103:521-525
Schwartz, Janice B; Gallagher, J Christopher; Jorde, Rolf et al. (2018) Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations. J Clin Endocrinol Metab 103:3278-3288
Qiao, Yu; Xu, Meng; Tao, Junyan et al. (2018) Oncogenic potential of N-terminal deletion and S45Y mutant ?-catenin in promoting hepatocellular carcinoma development in mice. BMC Cancer 18:1093

Showing the most recent 10 out of 1119 publications